首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   395篇
  免费   40篇
  国内免费   12篇
耳鼻咽喉   3篇
儿科学   4篇
妇产科学   10篇
基础医学   106篇
口腔科学   2篇
临床医学   6篇
内科学   64篇
皮肤病学   5篇
神经病学   41篇
特种医学   69篇
外科学   26篇
综合类   14篇
预防医学   36篇
眼科学   4篇
药学   18篇
中国医学   2篇
肿瘤学   37篇
  2023年   6篇
  2022年   5篇
  2021年   16篇
  2020年   17篇
  2019年   42篇
  2018年   20篇
  2017年   14篇
  2016年   15篇
  2015年   22篇
  2014年   23篇
  2013年   34篇
  2012年   19篇
  2011年   25篇
  2010年   15篇
  2009年   12篇
  2008年   20篇
  2007年   11篇
  2006年   23篇
  2005年   12篇
  2004年   14篇
  2003年   8篇
  2002年   5篇
  2001年   6篇
  2000年   5篇
  1999年   7篇
  1998年   6篇
  1997年   8篇
  1996年   2篇
  1995年   3篇
  1994年   3篇
  1993年   1篇
  1991年   1篇
  1990年   4篇
  1987年   3篇
  1986年   1篇
  1985年   6篇
  1984年   1篇
  1983年   4篇
  1982年   2篇
  1981年   2篇
  1980年   2篇
  1978年   1篇
  1977年   1篇
排序方式: 共有447条查询结果,搜索用时 46 毫秒
91.
MRI of hyperpolarized 129Xe dissolved in pulmonary tissues, and blood has the potential to offer a new tool for regional evaluation of pulmonary gas exchange and perfusion; however, the extremely short T and low magnetization density make it difficult to acquire the image. In this study, an ultrashort echo‐time sequence was introduced, and its feasibility to quantitatively assess emphysema‐like pulmonary tissue destruction by a combination of dissolved‐ and gas‐phase 129Xe lung MRI was investigated. The ultrashort echo‐time has made it possible to acquire dissolved 129Xe images with reasonably high spatial resolution of 0.625 × 0.625 mm2 and to obtain T of 0.67 ± 0.30 ms in a spontaneously breathing mouse at 9.4 T. The regional dynamic alveolar gas uptake as well as subsequent transport by pulmonary blood flow was also visualized. The ratio of 129Xe magnetization that diffused into the septa relative to the gas‐phase magnetization F was regionally evaluated. The mean F value of elastase‐treated mice was 2.28 ± 0.46%, which was significantly reduced from that of control mice 3.41 ± 0.48% (P = 0.0052). This reflects the reduced uptake efficiency due to alveolar tissue destruction and is correlated with the histologically derived alveolar surface‐to‐volume ratio. Magn Reson Med, 2013. © 2012 Wiley Periodicals, Inc.  相似文献   
92.
93.
Review of 2895 consecutive autopsies from 1962 to 1980 inclusive showed no significant differences in the prevalence of emphysema or other chronic lung disease between 282 active and retired employees of a cotton textile mill and the nontextile population. There was no statistical evidence that exposure to cotton dust, even after many years, produced emphysema, interstitial fibrosis, or cor pulmonale. The prevalence of emphysema in the series was highest in white males (22.0%), followed closely by black males (18.3%). In white females it was 7.5%, in black females, 5.5%. The prevalence in subjects under age 50 yr was 4.5%; in the age group 60-64 yr, 14.6%; and in subjects 65 yr of age and older, 21.9%. A significant increase in the prevalence of emphysema occurred between the 1962 to 1969 period and the 1970 to 1980 period.  相似文献   
94.
目的:探究乙型肝炎病毒表面抗原(HBsAg)终止密码子的存在状况及偏嗜性.方法:从GenBank中选取各基因型的参考序列共174例;使用生物软件BioEdit进行序列比对,应用RNAdraw构建并分析其RNA二级结构.结果:(1)在174例参考序列中,HBsAg的终止密码子共有TAA和TGA两种形式.其中TAA形式的有124例,占71.26%;TGA形式的有50例,占28.74%.(2)终止密码子的使用存在偏嗜性,并影响RNA的二级结构和蛋白质的编码氨基酸序列.结论:HBsAg终止密码子的使用偏嗜性客观存在,可能与进化过程中RNA结构和蛋白质功能的保守性相关.  相似文献   
95.
96.
We describe the clinical, neuropathological, immunohistochemical and transmission findings in three patients with Creutzfeldt-Jakob disease (CJD) with a substitution from methionine to arginine at codon 232 (M232R) in the prion protein (PrP) gene. The patients with M232R presented clinically with rapidly progressive dementia, myoclonus, and periodic synchronous discharges in the electroencephalogram. These findings were mostly consistent with those for sporadic CJD. All patients reached the stage of akinetic mutism between 2 and 6 months, and died between 4 and 24 months after the onset of the disease. Histopathological examination revealed spongiform changes, neuronal loss and severe astrocytosis. Immunohistochemical staining for PrP showed diffuse gray matter staining, including synaptic structures. However, no plaque-type PrP deposition was observed in the affected brain tissue sections. The brain homogenates from two patients were successfully transmitted to experimental animals. Since the same mutation was not found in 100 healthy control individuals, the mutation might be associated with the disease. The clinicopathological and experimental transmission studies of CJD patients with this PrP gene mutation may thus help us to determine both phenotypic variations and the potential infectivities in different forms of prion diseases. Received: 27 December 1995 / Revised, accepted: 25 March 1995  相似文献   
97.
98.
131I is one of the most important radionuclides used in nuclear medicine. The accompanying isotope 129I with insignificant activities in 131I-pharmaceuticals, produced in THOR, were determined in terms of 129I/131I ratio by neutron activation analysis. The detection limit of 129I can be lowered to order of 0.1 Bq, superior to conventional radiometric methods. The 129I/131I ratios in the 131I-pharmaceuticals, were measured to be in the range from 3.9 to 8.3.  相似文献   
99.
100.

Introduction

In this phase 2 study, we evaluated the activity of AUY922 in pretreated patients with stage IV NSCLC.

Methods

Patients with advanced NSCLC were divided into molecularly defined strata based on mutations in the EGFR gene, the ALK receptor tyrosine kinase gene (ALK), the KRAS gene, or the wild type of all three. All patients must have received more than two prior lines of therapy, except for those in a fifth stratum for a less pretreated EGFR cohort (EGFR<2). In the EGFR-mutant and ALK-rearranged strata, prior platinum therapy was not required. Patients with EGFR mutation must have received an EGFR tyrosine kinase inhibitor unless they had de novo resistance (e.g., T790M or exon 20 insertions). Eligible patients received weekly intravenous AUY922, 70 mg/m2. The primary objective was to estimate efficacy (complete or partial response, or in the absence of complete or partial response, stable disease) at 18 weeks, by the Response Criteria in Solid Tumors.

Results

A total of 153 patients from 21 global centers were enrolled from October 2010 to November 2014. The investigator-assessed overall response rate and stable disease rate at 18 weeks were 31.8% and 9.1% in the ALK-rearranged stratum, 17.1% and 8.6% in EGFR-mutant stratum, 9.7% and 22.6% in the EGFR<2 stratum, 0% and 7.1% in KRAS-mutant stratum, and 8.8% and 8.8% in wild-type stratum. Biomarker data showed activity of AUY922 in EGFR-mutant patients with exon 19 deletion, T790M mutation, and exon 20 insertion. The most common (≥40%) all-causality adverse events were diarrhea, nausea, and decreased appetite. Visual-related disorders were reported in 79.7% of patients (most were grade 1/2). Thirty-five patients (22.9%) reported night blindness.

Conclusion

AUY922 is active in patients with NSCLC, particularly among patients with ALK rearrangements and EGFR mutations.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号